Cargando…

Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention

Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hortová-Kohoutková, Marcela, Tidu, Federico, De Zuani, Marco, Šrámek, Vladimír, Helán, Martin, Frič, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566305/
https://www.ncbi.nlm.nih.gov/pubmed/32516170
http://dx.doi.org/10.1097/SHK.0000000000001541
_version_ 1783596118091759616
author Hortová-Kohoutková, Marcela
Tidu, Federico
De Zuani, Marco
Šrámek, Vladimír
Helán, Martin
Frič, Jan
author_facet Hortová-Kohoutková, Marcela
Tidu, Federico
De Zuani, Marco
Šrámek, Vladimír
Helán, Martin
Frič, Jan
author_sort Hortová-Kohoutková, Marcela
collection PubMed
description Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms.
format Online
Article
Text
id pubmed-7566305
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75663052020-10-29 Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention Hortová-Kohoutková, Marcela Tidu, Federico De Zuani, Marco Šrámek, Vladimír Helán, Martin Frič, Jan Shock Review Articles Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms. Lippincott Williams & Wilkins 2020-11 2020-06-08 /pmc/articles/PMC7566305/ /pubmed/32516170 http://dx.doi.org/10.1097/SHK.0000000000001541 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Shock Society. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Review Articles
Hortová-Kohoutková, Marcela
Tidu, Federico
De Zuani, Marco
Šrámek, Vladimír
Helán, Martin
Frič, Jan
Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
title Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
title_full Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
title_fullStr Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
title_full_unstemmed Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
title_short Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
title_sort phagocytosis–inflammation crosstalk in sepsis: new avenues for therapeutic intervention
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566305/
https://www.ncbi.nlm.nih.gov/pubmed/32516170
http://dx.doi.org/10.1097/SHK.0000000000001541
work_keys_str_mv AT hortovakohoutkovamarcela phagocytosisinflammationcrosstalkinsepsisnewavenuesfortherapeuticintervention
AT tidufederico phagocytosisinflammationcrosstalkinsepsisnewavenuesfortherapeuticintervention
AT dezuanimarco phagocytosisinflammationcrosstalkinsepsisnewavenuesfortherapeuticintervention
AT sramekvladimir phagocytosisinflammationcrosstalkinsepsisnewavenuesfortherapeuticintervention
AT helanmartin phagocytosisinflammationcrosstalkinsepsisnewavenuesfortherapeuticintervention
AT fricjan phagocytosisinflammationcrosstalkinsepsisnewavenuesfortherapeuticintervention